LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Steribite Announces Merger With Precision Manufacturing Group
Company News

Steribite Announces Merger With Precision Manufacturing Group

January 22, 2022 2 min read Premium comments

Advertisement

Secondary#precisionmanufacturing#steribite

Cleveland-based medical device company Steribite, LLC has announced it has merged with Wooster, Ohio-based contract manufacturer Precision Manufacturing Group, LLC (PMG).

“We are extremely pleased with this merger with our critical manufacturing partner. It will allow us to move additional manufacturing steps in-house, and with all the problems associated with the supply chain and manufacturing overseas, we think a completely U.S. manufactured product is critical to our success. It will enhance our value by reducing costs, manufacturing time, and improve our quality control. It will also give us another revenue source since PMG manufactures spinal implants and instruments for other companies, an area we want to grow,” said Steribite CEO John A. Redmond.

“We are excited to become part of the Steribite team. We’ve had a close relationship, as one of their key suppliers for the last few years and it is a natural fit to combine the two organizations,” said PMG CEO Casey Zace, who will become COO of Steribite.

New, privately held company Steribite develops surgical instruments and spinal implants and surgical instruments for patients and surgeons. Precision Manufacturing Group makes stainless-steel shafts used in Steribite’s kerrison rongeur, the company’s reusable bone removal instruments, used in spinal procedures.

Steribite received FDA clearance for its disposable kerrison rongeurs in 2018. Reusable kerrison rongeurs are difficult to clean and keep sharp, as well as being expensive. Disposable kerrison rongeurs eliminate these issues and decrease risk of surgical infection.

Redmond told OTW, “For 2022, we will be adding an 11-inch version of the Steribite kerrison and are developing other disposable products that are critical to the successful outcome of spinal procedures. Prior to our merger, PMG was making spinal implants and related products for other companies. We plan on growing that business as well.”

Redmond explained how the merger took place. “When we were looking for a manufacturer to make our stainless steel shafts, we tried to find a U.S. manufacturer, but we could not get anyone to give us the price we needed for a disposable instrument. We then tried China and the price was right, but the quality was inconsistent. Plus, the logistics were problematic in terms of shipping time, costs and communication. We also got quotes from a couple of German manufacturers, but again the cost was too high. Since the parts require very tight tolerances and needed some adjustments during the development stage, we realized we needed a small manufacturer that we could work closely with. An industry friend introduced me to PMG.”

Redmond continued, “We came to an agreement on the shaft cost, which was in-line with what we needed. We then made an initial investment in PMG that gave us a 20% stake and a board seat. Later, we made another investment that gave us a controlling interest with 51%. Steribite is a very complex product to make, with six different companies involved in the various stages. This was causing us time delays and no consistent production schedules we could count on. We came to the conclusion that we needed to bring more of the production steps in-house. To do that, it just made sense to completely merge with PMG.”

Redmond emphasized, “The benefits are tremendous, from increased profits, shorter production times and better quality control. With all the problems associated with the supply chain, and geopolitical uncertainties, we think owning a U.S. manufacturing facility is a great strategic move that increases our value tremendously.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy